Open AccessPersistence of clonal azole-resistant isolates of Candida albicans from a patient with chronic mucocutaneous candidiasis in Colombia
Author(s) -
Andrés Ceballos-Garzón,
Luz M Wintaco-Martínez,
Nórida Vélez,
Catalina Hernandez-Padilla,
Alejandro De la Hoz,
Sandra Valderrama-Beltrán,
Carlos Álvarez-Moreno,
Patrice Le Pape,
Juan David Ramírez,
Claudia Marcela Parra-Giraldo
Publication year - 2020
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/jgid.jgid_74_19
Subject(s) - fluconazole , voriconazole , caspofungin , genotyping , itraconazole , biology , chronic mucocutaneous candidiasis , azole , candida albicans , microbiology and biotechnology , posaconazole , corpus albicans , multilocus sequence typing , amphotericin b , broth microdilution , genotype , medicine , antifungal , antibiotics , minimum inhibitory concentration , genetics , disease , gene
The present article describes retrospectively a case of a patient with chronic mucocutaneous candidiasis (CMC) who presented recurrent Candida albicans infection since he was 6 months old. We obtained 16 isolates recovered during a 4-year period. Our purpose was to determinate the susceptibility, genotyping, and the pathogenicity profile in all the isolates.